License & Collaboration Revenue was Verrica Pharmaceuticals’s largest product and service line in fiscal 2025, bringing in $20.29M of $35.58M (57%).
| Product and Service | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| License & Collaboration Revenue | — | — | $992.00K | $20.29M |
| Product Revenue, Net | — | — | $6.57M | $15.29M |
| Product | — | $4.66M | — | — |
| Collaboration | $9.03M | $466.00K | — | — |
| Total | $9.03M | $5.12M | $7.57M | $35.58M |
Verrica Pharmaceuticals brought in $35.58M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 370.2% from $7.57M in fiscal 2024. License & Collaboration Revenue was the largest at $20.29M (57.0%), ahead of Product Revenue, Net at $15.29M (43.0%).
Compared with fiscal 2024, License & Collaboration Revenue grew 1,945.6% to $20.29M and Product Revenue, Net grew 132.5% to $15.29M.
Verrica Pharmaceuticals began breaking out License & Collaboration Revenue in fiscal 2024 and Product Revenue, Net in fiscal 2024. Verrica Pharmaceuticals stopped reporting Product ($4.66M in fiscal 2023) and Collaboration ($466.00K in fiscal 2023) as separate lines.
Verrica Pharmaceuticals (VRCA) reports its revenue by product and service. In fiscal 2025, License & Collaboration Revenue was its largest product and service line, bringing in $20.29M (57.0% of the total), followed by Product Revenue, Net at $15.29M (43.0%).
License & Collaboration Revenue was Verrica Pharmaceuticals' largest product and service line in fiscal 2025, bringing in $20.29M, or 57.0% of the $35.58M total across its two product and service lines.
License & Collaboration Revenue grew faster than Product Revenue, Net in fiscal 2025, up 1,945.6% from $992.00K to $20.29M. Product Revenue, Net grew 132.5% to $15.29M.
Every figure comes from Verrica Pharmaceuticals' annual financial filings, as reported. Each line keeps the name Verrica Pharmaceuticals gives it, and years follow its fiscal calendar.
Verrica Pharmaceuticals' revenue by product and service goes back to fiscal 2022, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.